Friday, June 5, 2026

FDA’s Game-Changing Guidelines: What Asian Biotech Firms Must Know About Clinical Trial Efficiency

Clinical Trial Design is crucial for success in pharma; FDA's new rules could ease burdens but raise quality standards.

How 144 Key Genes Could Revolutionize Cardiomyopathy Treatment: Insights from Recent Study

Researchers identified 144 key genes linked to cardiomyopathy, suggesting complex interactions among cell types may drive the condition.

Wang Yi’s Diplomatic Mission to North Korea: Enhancing Ties Before Key U.S.-China Talks

Wang Yi's visit to North Korea signals strategic talks to strengthen ties ahead of upcoming U.S.-China summit.

Dae Hyeon Moon

Author's Latest

CHA Biotech Partners With Thermo Fisher to Build K-Bio Open Innovation Hub in Pangyo

Cha Biotech partners with Thermo Fisher to establish K-Bio CIC, enhancing biotech innovation and global market entry support.

Yuhan to Receive $30 Million Milestone From European Launch of Lazertinib Combination Therapy

Yuhan Corporation receives a $30M milestone for Lazertinib's European launch, totaling $300M in payments, aiming for global healthcare leadership.

Samsung Epis Holdings Earns MSCI AA Rating in First Global ESG Assessment

Samsung Epis Holdings earns an AA ESG rating from MSCI, highlighting its commitment to sustainable management and biopharmaceutical growth.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

HLB Group Maps Commercialization Push as It Awaits Key U.S. Cancer Drug Decisions

HLB Group seeks FDA approval for cancer drugs, aiming for global impact through innovation and collaboration in the biotech sector.

AITRICS Secures Malaysia Approval for Patient Deterioration Prediction AI Platform

AITRICS gains Malaysian approval for its AI solution VitalCare, enhancing patient safety and expanding in Southeast Asia's healthcare market.

KDDF Chief Calls for Structural Shift in Korea Biotech Beyond Technology Transfer

Dr. Park Young-min urges South Korea's biotech sector to shift from tech transfer to global collaboration for sustainable growth.

Classys Showcases Expanding Aesthetics Portfolio at ASLMS 2026 as U.S. Push Accelerates

Classys showcases its innovative aesthetic devices at ASLMS 2026, aiming to lead the U.S. market with advanced treatments.

VUNO Study Shows Improved LVSD Screening Performance for AI-Based ECG Algorithm

VUNO's AI heart failure screening device shows improved accuracy through advanced algorithms, enhancing early detection and patient outcomes.

JLK Targets Medical Imaging and Clinical Text Integration With JOOMED Multimodal AI Platform

JLK's JOOMED integrates medical imaging with hospital data, enhancing analysis and insights for healthcare without competing with general AI.

Inventage Lab Secures Patent for Semaglutide Formulation Aimed at Improving Oral Bioavailability

Inventage Lab secures a patent for a liposome formulation enhancing semaglutide's bioavailability, aiming to lead in obesity treatment.

Hugel Broadens Collaboration With Korean Clinicians Through Regional Academic Events

Hugel is enhancing its presence in the Korean aesthetics market through academic programs and expanding into Indonesia with training events.

JPI Healthcare Expands From X-Ray Components Into AI-Based Digital Imaging Solutions

JPI Healthcare evolves into an AI-driven imaging platform, enhancing X-ray technology and expanding into tailored medical solutions.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.